Three-phase treatment offers patients with HSV infections an alternative to perpetual antiviral management ROATAN, BAY ...
1don MSN
Embassy Developments receives RERA approval for its first project in Alibaug; Eyes ₹400 crore GDV
Embassy Developments’ project in Alibaug covers approximately 0.2 million sq ft of RERA carpet area, with an estimated GDV of ...
Embassy Developments Ltd has received MahaRERA approval for Phase I of Embassy Serenity in Alibaug, marking its entry into the lifestyle and second-home segment. The 0.2 million square feet project, ...
Q VYJUVEK revenue and $730.3 million since U.S. launchFDA granted RMAT to KB707 for the treatment of advanced NSCLC and Fast ...
FDA RMAT boosts inhaled gene therapy KB707, delivering IL‑2/IL‑12 to lung tumors; early trial shows responses with manageable ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 12, 2026 / NanoViricides, Inc., a publicly traded company (NYSE ...
Embassy Developments Ltd. secured MahaRERA approval for its Embassy Serenity project in Alibaug, marking its entry into the ...
Detailed price information for Candel Therapeutics Inc (CADL-Q) from The Globe and Mail including charting and trades.
Creative Biolabs, a leader in viral vector engineering and immunotherapy solutions, has announced the expansion of its ...
Q VYJUVEK revenue and $730.3 million since U.S. launch FDA granted RMAT to KB707 for the treatment of advanced NSCLC and Fast Track Designation to KB111 for the treatment of HHD Strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results